34 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 31199148 | Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors. | 2019 Jul 25 | 2 |
2 | 29303363 | Isocitrate dehydrogenase 1 mutation subtypes at site 132 and their translational potential in glioma. | 2018 Jan | 1 |
3 | 29382206 | TOF-SIMS analysis of an isocitrate dehydrogenase 1 mutation-associated oncometabolite in cancer cells. | 2018 Jan 30 | 1 |
4 | 29670690 | Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers. | 2018 Apr 12 | 1 |
5 | 29743236 | IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53. | 2018 Jun 22 | 1 |
6 | 30194083 | Bridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas. | 2018 Sep-Oct | 1 |
7 | 27406240 | Point mutation (R153H or R153C) in Escherichia coli isocitrate dehydrogenase: Biochemical characterization and functional implication. | 2017 Jan | 2 |
8 | 26188014 | Isocitrate dehydrogenase mutations in gliomas. | 2016 Jan | 1 |
9 | 26967252 | Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes. | 2016 Apr 12 | 1 |
10 | 27956631 | The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development. | 2016 Dec 27 | 2 |
11 | 25324168 | Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas. | 2015 Jan | 3 |
12 | 25787993 | Isocitrate dehydrogenase mutations: new opportunities for translational research. | 2015 May | 1 |
13 | 25853107 | Identification of a new selective chemical inhibitor of mutant isocitrate dehydrogenase-1. | 2015 Mar | 3 |
14 | 26147657 | Role of isocitrate dehydrogenase 1/2 (IDH 1/2) gene mutations in human tumors. | 2015 Oct | 2 |
15 | 26198745 | Glandular differentiation in dedifferentiated chondrosarcoma: molecular evidence of a rare phenomenon. | 2015 Sep | 1 |
16 | 23235339 | Immunohistochemical demonstration of isocitrate dehydrogenase 1 (IDH1) mutation in a small subset of prostatic carcinomas. | 2014 Apr | 1 |
17 | 24590270 | Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation. | 2014 Jun | 1 |
18 | 24626950 | Mutation of isocitrate dehydrogenase 1 induces glioma cell proliferation via nuclear factor-κB activation in a hypoxia-inducible factor 1-α dependent manner. | 2014 May | 2 |
19 | 24898068 | Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of bone. | 2014 Jun | 4 |
20 | 23264629 | The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization. | 2013 Feb 8 | 3 |
21 | 21996744 | Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production. | 2012 May 10 | 1 |
22 | 22238332 | Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy. | 2012 Jan 11 | 1 |
23 | 22396072 | Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors. | 2012 Jul | 2 |
24 | 22442146 | Cancer-associated isocitrate dehydrogenase mutations inactivate NADPH-dependent reductive carboxylation. | 2012 Apr 27 | 1 |
25 | 22809434 | Mutation analysis of isocitrate dehydrogenase in acute lymphoblastic leukemia. | 2012 Aug | 1 |
26 | 22904127 | IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance. | 2012 Aug | 1 |
27 | 23090985 | Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation. | 2012 Dec | 1 |
28 | 23267435 | Promoter Methylation Analysis of IDH Genes in Human Gliomas. | 2012 | 1 |
29 | 21352804 | Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation. | 2011 Mar 25 | 2 |
30 | 21647154 | IDH1 and IDH2 mutations in pediatric acute leukemia. | 2011 Oct | 1 |
31 | 20142433 | Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. | 2010 Feb 15 | 1 |
32 | 20513808 | Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. | 2010 Jul 7 | 1 |
33 | 20692206 | IDH mutations in glioma and acute myeloid leukemia. | 2010 Sep | 1 |
34 | 23905201 | ML309: A potent inhibitor of R132H mutant IDH1 capable of reducing 2-hydroxyglutarate production in U87 MG glioblastoma cells | 2010 | 1 |